Testing for infectious agents causing cervical cancer

Every year 570,000 new cases, 311,000 deaths (1). In Vietnam, every 2.4 hours, a woman died from cervical cancer (2).

The HPV virus causes 100% of cervical cancers (1). There are more than 100 strains of HPV, 40 strains cause disease, at least 14 high-risk strains, two strains 16 and 18 account for 70% of cervical cancers, 2 strains 6 and 11 cause 90-95% of warts genital (3).

Screening for HPV can prevent up to 80% of cervical cancer (4).

Biomedic's solution

Using Real-time PCR-based kits has significant advantages over traditional Pap smears:

-Obtained CE-IVD certification for clinical diagnosis
– High precision
– Genotyping of different strains of HPV
– Early diagnosis
– Identification of high-risk virus strains
– Support the prevention and development of appropriate therapy for cervical cancer.


PANARealTyperTM HPV Screening Kit

PANARealTyperTM HPV Screening Kit is an in vitro diagnostic kit for the determination of the presence or absence of HPV virus (Human papilloma virus) using a peptide nucleic acid (PNA) probe.